These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4343096)

  • 41. [Levels of Epstein-Barr virus antibodies in the serum of children with acute lymphoblastic leukemia].
    Holý J; Hrodek O; Hynieová H; Petrtýlová K; Srajer J; Vanĕcek K
    Cesk Pediatr; 1981 May; 36(5):248-53. PubMed ID: 6266677
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunity to Epstein-Barr virus in cyclosporin A-treated renal allograft recipients.
    Crawford DH; Edwards JM
    Lancet; 1982 Jun; 1(8287):1469-70. PubMed ID: 6123746
    [No Abstract]   [Full Text] [Related]  

  • 43. [Importance and diagnosis of Epstein-Barr virus infection].
    Kuljić-Kapulica N; Krstić L; Budisin A; Kapulica I; Bojić I; Malesević M; Kalinić-Andrić V
    Vojnosanit Pregl; 1991; 48(4):313-6. PubMed ID: 1660212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus and depression.
    DeLisi LE; Nurnberger JS; Goldin LR; Simmons-Alling S; Gershon ES
    Arch Gen Psychiatry; 1986 Aug; 43(8):815-6. PubMed ID: 3015068
    [No Abstract]   [Full Text] [Related]  

  • 45. [Anti-Epstein-Barr virus IgM antibodies in viral hepatitis A and B: significance and prevention].
    Freymuth F; Foucaut P; Quibriac M; Petitjean J; Ajchenbaum F; Pujol M
    Gastroenterol Clin Biol; 1986 May; 10(5):441-2. PubMed ID: 3015707
    [No Abstract]   [Full Text] [Related]  

  • 46. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients.
    Morrow RH; Sever JL; Henderson BE
    Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991
    [No Abstract]   [Full Text] [Related]  

  • 47. [Diagnostic significance of determining antibodies to antigens of the Epstein-Barr virus in infectious mononucleosis].
    Urazova LN; Podoplekin VD; Odintsova LN; Lepekhin AV
    Lab Delo; 1989; (5):73-4. PubMed ID: 2473271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic significance of antibodies to the Epstein-Barr virus-specific membrane antigen gp250.
    Jilg W; Wolf H
    J Infect Dis; 1985 Jul; 152(1):222-5. PubMed ID: 2989385
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of long-term low dose radiation--Epstein-Barr virus-specific antibodies in radiological technologists.
    Kumagai E; Tanaka R; Kumagai T; Higashida Y; Onomichi M; Nakamura I; Tanoue S; Katsuki T; Sawada S
    J Radiat Res; 1988 Sep; 29(3):203-10. PubMed ID: 2849681
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunopathology of infectious mononucleosis and other complications of Epstein-Barr virus infections.
    Purtilo DT
    Pathol Annu; 1980; 15(Pt 1):253-99. PubMed ID: 6255399
    [No Abstract]   [Full Text] [Related]  

  • 51. [Two cases of Epstein-Barr virus encephalitis with action tremor in elderly patients].
    Yabuki S; Kazahaya Y; Kubonishi I
    Rinsho Shinkeigaku; 1982 Sep; 22(9):783-8. PubMed ID: 6297839
    [No Abstract]   [Full Text] [Related]  

  • 52. Elevated serum antibody titers to Epstein-Barr virus in HTLV-I-associated myelopathy (HAM).
    Itoyama Y; Minato S; Goto I; Okochi K; Yamamoto N
    Neurology; 1988 Oct; 38(10):1650-3. PubMed ID: 2901698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epstein-Barr virus-associated membrane-reactive antibodies during long term survival Burkitt's lymphoma.
    Gunvén P; Klein G; Clifford P; Singh S
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1422-6. PubMed ID: 4364538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neutralizing antibodies to Epstein-Barr virus in healthy populations and patients with infectious mononucleosis.
    Hewetson JF; Rocchi G; Henle W; Henle G
    J Infect Dis; 1973 Sep; 128(3):283-9. PubMed ID: 4353929
    [No Abstract]   [Full Text] [Related]  

  • 55. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
    Yang CS; Hewetson JF
    Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
    [No Abstract]   [Full Text] [Related]  

  • 56. [Correlation of the level of humoral antibodies to the Epstein-Barr virus and the clinical course of atherosclerosis].
    Kupchinskiĭ RA; Matskin LI; Azarovskaia TN; Stepina VN
    Vopr Virusol; 1988; 33(4):479-81. PubMed ID: 2848370
    [No Abstract]   [Full Text] [Related]  

  • 57. Epstein-Barr virus and nasopharyngeal cancer.
    Poole E; Stewart IA
    N Z Med J; 1984 Apr; 97(753):239. PubMed ID: 6326009
    [No Abstract]   [Full Text] [Related]  

  • 58. Antibodies to Epstein-Barr virus, cytomegalovirus, and Australia antigen in Hodgkin's disease.
    Langenhuysen MM; Cazemier T; Houwen B; Brouwers TM; Halie MR; The TH; Nieweg HO
    Cancer; 1974 Aug; 34(2):262-7. PubMed ID: 4368421
    [No Abstract]   [Full Text] [Related]  

  • 59. [Studies on the levels of specific antibodies to Epstein-Barr virus and heterophile antibody in the patients with infection mononucleosis].
    Yagura H; Katsura Y; Funahashi S
    Rinsho Byori; 1989 Feb; 37(2):164-8. PubMed ID: 2543850
    [No Abstract]   [Full Text] [Related]  

  • 60. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies.
    Jones JF; Ray CG; Minnich LL; Hicks MJ; Kibler R; Lucas DO
    Ann Intern Med; 1985 Jan; 102(1):1-7. PubMed ID: 2578266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.